Non-cell Autonomous Hyperexcitability Underlies Focal Epileptogenesis Mediated by Low-Level Brain Somatic Mutations in MTOR
Abstract number :
3.016
Submission category :
1. Basic Mechanisms / 1B. Epileptogenesis of genetic epilepsies
Year :
2021
Submission ID :
1825528
Source :
www.aesnet.org
Presentation date :
12/6/2021 12:00:00 PM
Published date :
Nov 22, 2021, 06:44 AM
Authors :
Hyun Yong Koh, MD PhD - Boston Children's Hospital; Jaeson Jang, PhD - Bio and Brain Engineering - Korea Advanced Institute of Science and Technology (KAIST); Sang Hyeon Ju, MD - Biological Sciences - Korea Advanced Institute of Science and Technology (KAIST); Ryunhee Kim, PhD - Korea Advanced Institute of Science and Technology (KAIST); Dong Seok Kim, MD PhD - Yonsei University College of Medicine; Jong-Woo Sohn, MD PhD - Korea Advanced Institute of Science and Technology (KAIST); Se-Bum Paik, PhD - Korea Advanced Institute of Science and Technology (KAIST); Jeong Ho Lee, MD PhD - Korea Advanced Institute of Science and Technology (KAIST)
Rationale: Low-level somatic mutation in neurons in the brain causes intractable focal epilepsy, including focal cortical dysplasia type 2 (FCD II) (Lim et al. Nat Med 2015;21:395-400) and ganglioglioma (Koh et al. Nat Med 2018;24:1662-1668). Neurons carrying somatic mutations in ~1-2% of MTOR, TSC1, or TSC2 were found to induce epileptogenesis with spontaneous behavioral seizures. However, how only a few mutated cells in focal brain regions are able to elicit synchronized electrical discharges leading to epilepsy through disrupting the local network remains poorly understood.
Methods: We generated FCD II model mice having a somatic mutation in MTOR L2427P presenting seizures by in utero electroporation and ascertained the number of mutated neurons (MTORL2427P) throughout the whole brain along with patients-derived tissue. To probe the origin of epileptogenesis, we measured the neuronal excitability in MTORL2427Pand nearby non-mutated neurons (L2427Pnearby) by current injection and multi-electrode recording comparing the topographic distribution of cells having the mutation. Computational connectivity using the leaky-integrate-and-fire model recapitulates network changes based on measured properties. To examine the underlying mechanism, we measured excitatory and inhibitory (E-I) synaptic inputs in MTORL2427P and L2427Pnearby by electrophysiological and immunofluorescence studies. To explain non-cell autonomous hyperexcitability, an inhibitor of adenosine kinase (ADK), which translation was increased by MTORL2427P in ribosome-sequencing, was injected into mice in vivo.
Results: Only 1.85±0.80% of neurons carried the MTOR somatic mutation in the whole epileptic-brain (Fig. 1A). Interestingly, the seizure-triggering hyperexcitability was originated from L2427Pnearby, but MTORL2427P was less excitable than L2427Pnearby. This suggests that neurons carrying MTORL2427P may not be the source of the hyperactivity observed. Our comprehensive data from computational simulations and immunofluorescence and electrophysiological experiments implicated non-cell autonomous effects in the hyperexcitability of nearby non-mutated neurons (Fig. 1B and C), rather than cell-autonomous or intrinsic properties in mutated neurons, such as an increased cell size and an alternation of synaptic connectivity. E-I synaptic inputs onto MTORL2427P remained unchanged in mice and FCD II patients’ tissues, implying that intrinsic synaptic changes driven by MTOR mutation are less likely to be explanatory. Instead, we found that inhibition of ADK, an extrinsic factor induced by neurons carrying MTORL2427P, reduced the hyperexcitability of L2427Pnearby affecting adenosine metabolism in the local network (Fig. 2).
Conclusions: Taken together, providing an example of how low-level brain somatic mutation can change the entire brain activity, this study showed that neurons carrying somatic mutations in MTOR lead to focal epileptogenesis via non-cell autonomous hyperexcitability of nearby non-mutated neurons.
Funding: Please list any funding that was received in support of this abstract.: Suh Kyungbae Foundation and the Korean Health Technology Research and Development Project (H15C3143) and National Research Foundation (2019R1A2C2005161, 2019R1A2C4069863 and 2019R1A3B2066619).
Basic Mechanisms